Saw palmetto quality
This article was originally published in The Tan Sheet
Executive Summary
Seventeen of 27 saw palmetto products examined by ConsumerLab.com meet the online independent test firm's quality standards. The other randomly selected products failed due to labeling disclosing low fatty acid levels (five products), incomplete dosage information on labeling (one product) and insufficient fatty acid and/or sterol levels as measured by gas chromatographic analysis (four products). "At least 85% of the weight of clinical quality saw palmetto products are expected to be attributable to specific fatty acids and sterols," the company notes. Saw palmetto is the second herbal ingredient to be tested by the Web firm; results on ginkgo biloba were released in November (1"The Tan Sheet" Nov. 29, 1999, p. 23). Data on glucosamine and chondroitin products are expected in February
You may also be interested in...
CR Saw Palmetto Review Produces Mixed Results; More Tests Upcoming
Only eight of 13 saw palmetto supplements tested by Consumer Reports contain an adequate amount of the extract, the magazine reports in its September issue.
Low Chondroitin Levels Due To Poor Quality Control, Cost - ConsumerLab.com
Poor quality control and the high cost of chondroitin are likely to blame for below-label levels of the dietary supplement ingredient found in eight of 25 products examined by ConsumerLab.com, the company reported.
ConsumerLab.com Ginkgo Tests Show 75% Labeling Accuracy Rate
Three-quarters of ginkgo biloba products tested by ConsumerLab.com contained the levels of the botanical ingredient claimed on labeling, the online nutritional products testing firm announced Nov. 16.